Telogen effluvium as a symptom of “Long Covid” in patients pre-infected with SARS-CoV-2: an integrative literature review

Authors

DOI:

https://doi.org/10.33448/rsd-v11i13.36183

Keywords:

COVID-19; SARS-CoV-2; Telogen effluvium.

Abstract

COVID-19 is a relatively new disease that presents a broad spectrum of clinical manifestations, among them is telogen effluvium, a condition that promotes diffuse hair loss in the patient, usually after the end of the infection. This article is a narrative literature review that seeks to understand the pathogenesis of telogen effluvium, as well as the impacts of this symptom on patients' lives. For this, a search was carried out in the following databases: National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) and EBSCO Information Services in order to collect the most current information on the topic. Thus, it was noted that telogen effluvium was a complex symptom, as it probably involves more than one mechanism in its pathogenesis. In addition, the study is justified by the effect it has on the self-esteem and self-image of patients who, seeing their hair fall out, have their emotional stress increased. With regard to treatment, correction of the triggering factor, combined with the implementation of a protein-rich diet, proved to be effective in stopping hair loss.

References

Aksou, H. et al. (2021). COVID‐19 induced telogen effluvium. Dermatologic Therapy, 34 (15175).

Alam, M., et al. (2021). Cutaneous manifestations of COVID-19: Characteristics, pathogenesis, and the role of dermatology in the pandemic. Cutis, 107 (4), 209–215.

Araujo, V. C., et al. (2022). Eflúvio Telógeno após a infecção por COVID 19: uma revisão narrativa sobre o mecanismo fisiológico / Telogen Effluvium after SARS-CoV-2 infection: a narrative review of physiological mechanism. Brazilian Journal of Health Review, 5 (3), 10157–10164.

Asghar, F., et al. (2020). Telogen Effluvium: A Review of the Literature. Cureus, 12 (5), 1–7.

Cristina, P., Macedo, Q. D. & Lima, C. (2022). Eflúvio Telógeno Agudo e Alopecia Areata Associada a COVID-19. Brazilian Journal of Health Review, 1 (8), 1–9.

Figueiredo, B. Q., et al. (2021). Mapeamento da “Covid longa ” em pacientes assistidos pela USF Itamarati e previamente infectados por SARS-CoV-2. Research, Society and Development, 12 (1), 1–6.

Fernandes, I. M.,, et al. (2021). Manifestações dermatológicas durante e após a COVID-19: Uma revisão narrativa / Dermatological manifestations during and after Covid-19: A narrative review. Brazilian Journal of Health Review, 4 (5), 20999–21009.

Gabrielle, M. A., et al. (2022). Eflúvio telogeno pós-COVID. Research, Society and Development, 1–7.

Gupta, A. et al. (2020). Extrapulmonary manifestations of COVID-19. Nature medicine, 26 (8), 1017-1032.

Helmy, Y. et al. (2020). The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. Journal of clinical medicine, 9 (1225).

Hussain, N. et al. (2021). A systematic review of acute telogen effluvium, a harrowing post‐COVID‐ 19 manifestation. Journal of medical virology, 7 (9).

Izumi, M. O. & Brandão, B. J. (2021). Tratamento do Eflúvio Telógeno Pós-Covid 19. BWS Journal, 4 (1), 1–8.

Mieczkowska, K., et al. (2021). Telogen effluvium: a sequela of COVID‐19. International Journal of Dermatology, 6 (8).

Millett, G. A., et al. (2020). Assessing differential impacts of COVID-19 on black communities. Annals of epidemiology, 47 (1), 37-44.

Natário, J. A., et al. (2022). A queda capilar pode ser considerada uma das consequências da COVID-19? Research, Society and Development, 11 (1).

Nykolaichuk, K., et al. (2021). Pós-covid-19 telogen effluvium. Wha tis the razon? InterConf., 6 (2), 302-306.

Olds, H. et al. (2021). Telogen effluvium associated with COVID-19 infection. Dermatologic therapy, 34 (2).

Rivetti, N. & Barruscotti, S. (2020). Management of telogen effluvium during the COVID-19 emergency: Psychological implications. Dermatologic Therapy, 33 (4).

Sharquie, K. E. & Jabbar, R. I. (2021). COVID-19 infection is a major cause of acute telogen effluvium. Irish Journal of Medical Science, 1 (8), 19–23.

Sousa, J. A. B., et al. (2022). Aumento da queda capilar em pessoas acometidas por Sar-Cov2 / Increased hair loss in people affected by Sar-Cov2. Brazilian Journal of Development, 8 (3), 19336–19350.

Published

14/10/2022

How to Cite

FIGUEIREDO, B. Q. de .; SILVA, A. F. de O. D.; AMORIM, G. S.; BRITO, M. P. S.; NAVES, P. G. R.; BOAVISTA, R. T. T. M.; SILVA, T. M. da .; FRANÇA, L. de A.; BORGES, Y. J. Telogen effluvium as a symptom of “Long Covid” in patients pre-infected with SARS-CoV-2: an integrative literature review. Research, Society and Development, [S. l.], v. 11, n. 13, p. e599111336183, 2022. DOI: 10.33448/rsd-v11i13.36183. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/36183. Acesso em: 22 nov. 2024.

Issue

Section

Health Sciences